ASTRO/ILROG Joint Session - When Every Centigray Counts: Expert Panelists on Approaching and Optimizing the Most Challenging Lymphoma Plans
Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.
Category
  • Other
  • Leuk/Lymph/Hema
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Advancing Our Multi-Disciplinary Understanding of the Cardiovascular Considerations with Radiation Therapy
While radiation therapy (RT) is a highly effective treatment for many solid tumors, thoracic RT carries a risk of cardiovascular (CV) morbidity and mortality that limits critical gains in cancer control and survival.
Category
  • Other
  • Patient Safety
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Gray Zone - Put on Your Thinking Cap: A Fungating Scalp Mass
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Other
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Advancement in Imaging for Radiation Oncology
Various advances in imaging are changing the clinical practice for Radiation Oncology.
Category
  • Other
  • Physics
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Anal Cancer: Across the Spectrum of Care
Anal cancer rates are increasing, and there is a need to improve coordination across the spectrum of anal cancer care, from diagnosis, treatment, recovery and survivorship. Failure to understand the roles of all the multidisciplinary aspects of care leads to suboptimal patient care.  
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Gray Zone - Cervical Cancer with Vaginal Recurrence and Prior Pelvic Radiation
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Gynecologic Cancer
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
Challenging Cases in Patient Safety: The Nation’s Experience Navigating New Technologies as Told to RO-ILS
When implementing newer technologies practices often rely on vendor training, an evaluation of published literature, and collaboration with others experienced in the technology. Incident learning has a critical role in radiation therapy and may be most important in new and emerging technologies.
Category
  • Non Clinical Skills
  • Other
  • Patient Safety
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Oligometastatic Breast Cancer: Considering Patients One by One
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
  • SBRT
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Stereotactic Radiotherapy and Renal Cell Cancer: Overcoming Radioresistance and the Resistance to Radiate
The use of SABR is well established in many cancers, however, its application within kidney cancer is relatively new. This is largely due to the historical notion that renal cell carcinoma (RCC) is highly radioresistant.
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance

Pages